Who is Synapses?

Hi, I'm Jamie Love, the founder of Synapses.

I was born in the USA but moved to Scotland in 1990 to do a post-doc. I saw commercial potential in my research so, over the next two years in my spare time, I earned an MBA and wrote business plans, but, sadly, it never got off the ground.
If only I had known then, what I know now.

About a month after the university awarded me a permanent post, my British wife was offered an exciting job at a start-up near San Francisco! I resigned from the university and returned to the States where I discovered that my MBA and PhD fit well in Intellectual Property.

I worked with world class biotech patent lawyers to submit our patent applications to the USPTO, respond to Office Actions and represent our company during infringement proceedings.

I gained enough knowledge about the process that I submitted a patent application "pro se" (without a layer, as a co-inventor) and studied to become a USPTO certified patent agent.

A large patent law firm hired me to conduct Prior Art searches and write opinions on patentability for WIPO applications (outsourced from the USPTO).

In 2008 I returned to Scotland and co-founded a biotech company. As Managing Director, I negotiated our IP portfolio and wrote a business plan that encouraged an investor to provide some seed money - then nearly doubled that money with grants. With the interesting work done, I handed over the reigns to a CEO. As Chief Operations Officer I continued to manage the IP and grants for the company, but my reduced responsibilities allowed me time to help other start-ups.

My most recent post was at the University of Edinburgh, where I helped Masters and PhD students from local universities to start up their own companies. It was a great job - I helped an endless stream of energetic, creative and brilliant young inventors to protect their IP, write their business plans and turn their ideas into start-ups. Unfortunately, my Parkinson's Disease (diagnosed in 2007) caught up with me. The frenetic pace, commitments and long commute was too much so I retired in 2016. However, I have not retired my brain. I keep in touch with several of my "favorite student startups", providing advice and assistance pro bono, and also help others start ups who compensate me with cash or shares.

    Start-ups I'm helping or recently helped include:
  • a therapeutics company preparing for clincal trials for its potent, wound-healing molecules which have a novel and unique mode of action and that are protected by patents in Germany, France and the UK (until 2025), the US (until 2031) and Japan (until 2032).
  • another therapeutics company with novel immune-regulatory proteins, protected by a US patent until 2026, which can be used to prevent and fight infections, as well as treat autoimmune diseases and cancer.
  • a drug discovery company that uses traditional Indian medicines (Ayurveda) to provide lead compounds which are analysed in silico using state-of-the-art bioinformatics and molecular modeling, then validated in tissue culture, and finally redesigned to optimize them (making them patentable).
  • a manufacturing company that uses engineered plant cells to provide drugs and fine chemicals that are currently made by labour-intensive and land-intensive methods which deliver low and inconsistent yields.
  • a wave energy company that uses a hinged raft with innovative geometry to provide low-cost, single-point mooring that allows the machine to yaw (like a weather vane) so it naturally faces the direction from which most wave energy arrives, giving it good survivability and more power per size.

Return to the Synapses Home Page
Email Synapses

(© Dr Jamie Love 2017)